Release Date: 07/06/16 17:31 Summary: Annual Report to shareholders-ILH.AX Price Sensitive: No Download Document 7.17MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%